Instil Bio, Inc. (TIL)
5.70
-0.07
(-1.21%)
USD |
NASDAQ |
Oct 22, 16:00
5.725
+0.02
(+0.44%)
After-Hours: 20:00
Instil Bio Price : 5.70 for Oct. 22, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 22, 2026 | 5.80 | 5.94 | 5.68 | 5.70 | 84883.00 |
| Oct 21, 2026 | 6.01 | 6.09 | 5.73 | 5.77 | 40868.00 |
| Oct 20, 2026 | 5.88 | 6.19 | 5.85 | 5.94 | 100161.0 |
| Oct 19, 2026 | 5.89 | 6.35 | 5.62 | 5.79 | 147896.0 |
| Oct 16, 2026 | 6.18 | 6.45 | 5.91 | 5.91 | 25174.00 |
| Oct 15, 2026 | 6.08 | 6.495 | 6.08 | 6.13 | 33024.00 |
| Oct 14, 2026 | 6.06 | 6.22 | 5.93 | 5.95 | 44119.00 |
| Oct 13, 2026 | 6.611 | 6.611 | 6.025 | 6.18 | 27606.00 |
| Oct 12, 2026 | 6.65 | 6.66 | 6.51 | 6.58 | 11333.00 |
| Oct 09, 2026 | 6.69 | 6.76 | 6.53 | 6.74 | 37620.00 |
| Oct 08, 2026 | 6.84 | 6.895 | 6.41 | 6.56 | 54498.00 |
| Oct 07, 2026 | 6.89 | 7.00 | 6.85 | 6.90 | 7274.00 |
| Oct 06, 2026 | 7.220 | 7.220 | 6.82 | 6.885 | 24192.00 |
| Oct 05, 2026 | 7.22 | 7.35 | 6.95 | 6.95 | 12945.00 |
| Oct 02, 2026 | 7.19 | 7.44 | 7.15 | 7.22 | 28551.00 |
| Oct 01, 2026 | 7.15 | 7.30 | 7.13 | 7.235 | 5201.00 |
| Sep 30, 2026 | 7.19 | 7.385 | 7.14 | 7.24 | 8701.00 |
| Sep 29, 2026 | 7.04 | 7.23 | 7.04 | 7.14 | 4130.00 |
| Sep 28, 2026 | 7.115 | 7.16 | 7.03 | 7.04 | 11568.00 |
| Sep 25, 2026 | 7.05 | 7.17 | 7.05 | 7.17 | 9505.00 |
| Sep 24, 2026 | 7.14 | 7.24 | 7.05 | 7.12 | 8362.00 |
| Sep 23, 2026 | 7.030 | 7.38 | 7.030 | 7.235 | 11584.00 |
| Sep 22, 2026 | 7.02 | 7.20 | 7.00 | 7.13 | 23894.00 |
| Sep 21, 2026 | 7.09 | 7.20 | 6.92 | 7.07 | 69053.00 |
| Sep 18, 2026 | 7.13 | 7.21 | 7.08 | 7.09 | 27516.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.31 |
| Alnylam Pharmaceuticals, Inc. | 227.28 |
| Anika Therapeutics, Inc. | 21.09 |
| Savara, Inc. | 4.54 |
| Vericel Corp. | 42.97 |
Price Related Metrics
| Price to Book Value | 0.36 |
| Earnings Yield | -78.46% |
| Market Cap | 38.66M |